作者: Christel Florentina E. Van Den Eynde , Herman Augustinus De Kock , Pierre Jean-Marie Bernard Raboisson , Gerben Albert Eleutherius Van't Klooster
DOI:
关键词:
摘要: The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). is useful improve bioavailability inhibitor. As such, for treating conditions associated with Hepatitis C virus in patients. Pharmaceutical compositions kits this combination, processes preparing pharmaceutical formulations are also provided.